Lorenzo Guglielmetti

4 ta ish

French National Centre for Scientific Research

1. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Zhiyi Lan, Nafees Ahmad, Parvaneh Baghaei +35

   Sharh maqolaOAOchiq kirish20204 iqtibos

   ABIABI:AkademIndex/2026.other.006851

2. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

   Nafees Ahmad, Shama D. Ahuja, Onno W. Akkerman +97

   Sharh maqolaOAOchiq kirish20184 iqtibos

   ABIABI:AkademIndex/2026.other.034216

3. Eligibility for the Shorter Multidrug-Resistant Tuberculosis Regimen: Ambiguities in the World Health Organization Recommendations

   Francis Varaine, Lorenzo Guglielmetti, Helena Huerga +5

   Boshqa20162 iqtibos

   ABIABI:AkademIndex/2026.other.027998

4. Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe

   Christoph Lange, Raquel Duarte, M. Jachym +7

   Boshqa20162 iqtibos

   ABIABI:AkademIndex/2026.other.363668